Earlier Intervention Can Decrease Hospitalizations for COVID-19
Drug Topics
OCTOBER 19, 2022
Implementing mask mandates even days earlier can cause a decrease in the number of cumulative hospitalizations due to COVID-19.
Drug Topics
OCTOBER 19, 2022
Implementing mask mandates even days earlier can cause a decrease in the number of cumulative hospitalizations due to COVID-19.
PharmaVoice
OCTOBER 19, 2022
Major recent trial flops and what they mean for companies, patients and the industry.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
OCTOBER 19, 2022
Improving vaccination rates for the most common STI in the United States could be as simple as increasing knowledge about HPV.
PharmaVoice
OCTOBER 19, 2022
Is the industry ready for a biologic discovery revolution? Charlotte Deane, chief scientist of biologics AI at Exscientia, thinks so.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
OCTOBER 19, 2022
The authorization offers another COVID-19 booster choice for adults.
Pharmacy Times
OCTOBER 19, 2022
By targeting the viral conical core, these ARTs could disrupt the process of assembly and/or disassembly of the virus and result in its suppression.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Drug Store News
OCTOBER 19, 2022
The scholarships represent a commitment to an inclusive community and promoting diversity of thought, background, perspective and experience to advance pharmacy education and improve patient health.
Drug Topics
OCTOBER 19, 2022
Guidelines for prescribing antibiotics in the dental setting should be revisited.
Pharmacy Times
OCTOBER 19, 2022
More than 90% of independent pharmacy customers want technology to enhance their experience. Is your pharmacy ready?
Drug Topics
OCTOBER 19, 2022
Viral coinfections may become more common as COVID-19 restrictions continue to relax.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
OCTOBER 19, 2022
Since the world began confronting a global outbreak of monkeypox in the spring, the scientific community has had plenty of reasons to rue the fact that for decades this virus has been understudied. Here’s another one: Because of that oversight, doctors treating people who have been infected with monkeypox can’t answer with certainty whether some of them will face any long-term health consequences, referred to as sequelae in the field of medicine.
Pharmacy Times
OCTOBER 19, 2022
Seventeen percent work in hospital settings, including compounding, inpatient, medication reconciliation, and outpatient areas.
Pharmaceutical Technology
OCTOBER 19, 2022
Eli Lilly and Company has signed a definitive agreement for the acquisition of all outstanding shares of precision genetic medicine firm Akouos for a total deal value of up to nearly $610m or up to $15.50 for each share in cash. The deal comprises an acquisition value of $12.50 for each share in cash payable at closing along with one non-tradeable contingent value right per share (CVR) of up to another $3 in cash.
Pharmacy Times
OCTOBER 19, 2022
Case studies highlight recent developments and trends in pharmacologic treatments for migraine.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
pharmaphorum
OCTOBER 19, 2022
Frontiers Health 2022 in Milan is LIVE! Opening Day One will be Healthware Group’s CEO and founder Roberto Ascione and WTF Health’s founder and host Jessica DaMassa. The day’s keynote addresses will include ‘The H is for humanity’ by MD of Taliossa Tony Estrella and founder and trustee of Rachel’s House Lynna Chandra, as well as ‘Creative disruption in delivering novel VR solutions in pain: evidence, teamwork, and delivery’ by Christopher Eccleston, professor of medical psychology at the U
Pharmacy Times
OCTOBER 19, 2022
If pharmacists increasingly take up the prescribing mantle, then they must see to their competence to exercise that authority.
Drug Store News
OCTOBER 19, 2022
U.S. Sen. Amy Klobuchar (D-Minn.) and U.S. Sen. Mike Lee (R-Utah) announced they will hold a hearing in November to examine the proposed merger.
Pharmacy Times
OCTOBER 19, 2022
The study confirmed that patients with psoriasis are considered to have an increased risk for both chronic kidney disease and ESRD, because inflammation plays a significant role in those conditions as well as heart disease.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
OCTOBER 19, 2022
The Food and Drug Administration announced Wednesday that it has authorized a booster shot for Novavax’s Covid-19 vaccine. Unlike the latest boosters from Pfizer-BioNTech and Moderna, which target both the original strain of SARS-CoV-2 and the Omicron BA.4/5 variants, the Novavax booster only targets the original strain. The company announced in late May that it was studying an Omicron-targeting strain, as well as a bivalent booster.
Pharmacy Times
OCTOBER 19, 2022
The TaqMan SARS-CoV-2, Flu A/B, RSV RT-PCR multiplex assay can differentiate between 3 different viral infections (including COVID-19), making it highly cost-effective.
STAT
OCTOBER 19, 2022
A large commercial insurer’s decision to cover a controversial class of software-based treatments for psychiatric and other conditions could prove to be a landmark moment in the development of these so-called prescription digital therapeutics, which until now had been unable to secure coverage from insurers skeptical that the new technologies are as effective as their makers claim.
Pharmacy Times
OCTOBER 19, 2022
NCPA will appeal Express Scripts’ decision to reduce access to medications, following a contract with the Department of Defense.
pharmaphorum
OCTOBER 19, 2022
Synthetic biology specialist Synlogic will start phase 3 testing of a drug for rare metabolic disorder phenylketonuria (PKU) next year, after reporting solid proof-of-concept data. PKU is a rare genetic disease that manifests at birth and is marked by an inability to break down phenylalanine (phe), an amino acid that is commonly found in many foods.
Drug Store News
OCTOBER 19, 2022
Lannett's deal call for another pharmaceutical company to purchase and distribute under a private label a limited number of certain other Lannett owned generic drug products.
Aureus Medical Group
OCTOBER 19, 2022
Traveling. The word itself has so many stereotypes and misconceptions, especially when it comes to healthcare traveling. I want to bring light to a few of those misconceptions so more people fall in love with traveling. Read on for the top six myths that I believe are most common in the traveling industry. Myth #1: “It’s too hard to travel with kids or family.” Many clinicians travel with partners, children, relatives, pets, and even friends!
European Pharmaceutical Review
OCTOBER 19, 2022
The US Food and Drug Administration (FDA) has awarded a total of $38 million in the form of 19 new grants and two new contracts, to facilitate the upcoming four years of clinical trials and regulatory tools for rare diseases. Sandra Retzky, Director of the FDA’s Office of Orphan Products Development (OOPD) explained: “The contracts aim to help inform regulatory decision making and promote diversity, equity and inclusion in clinical research.”.
pharmaphorum
OCTOBER 19, 2022
From diagnosis to treatment and ongoing condition management, the patient journey is becoming an increasingly digitised one – a process which has been massively accelerated by the Covid pandemic and has significant implications for pharma & their patients vs. their customers. Join us on Monday 7 th November at 12:30 GMT / 13:30 CET / 7:30 am EDT as panellists focus on how this new paradigm is shaping both the industry’s omnichannel engagement and the patient care journey, from patient identi
European Pharmaceutical Review
OCTOBER 19, 2022
Eli Lilly is set to acquire Akouos, Inc, a precision genetic medicine company developing first-in-class adeno-associated viral gene therapies for treating inner ear conditions like sensorineural hearing loss. . Akouos’s lead product candidate AK-OTOF , is a gene therapy that treats hearing loss caused by mutations in the otoferlin gene (OTOF). .
Drug Store News
OCTOBER 19, 2022
Walmart is partnering directly with creators, providing tools and resources on one convenient platform.
European Pharmaceutical Review
OCTOBER 19, 2022
Methods for strain comparison and differentiation of environmental isolates. Identification of environmental isolates is a regular requirement in pharmaceutical manufacturing, and strain differentiation can be valuable in a variety of circumstances. There have been huge advances in the technology available for sequencing bacterial genomes, which has fed through to the analyses that are available to pharmaceutical microbiologists.
pharmaphorum
OCTOBER 19, 2022
Medical communications are in a state of transition. Due to the combined impact of emerging technologies, changing provider preferences, and an evolving post-pandemic world, pharma must navigate new ways to engage providers with relevant, science-driven, digital content. Delivering these materials in the proper format, however, requires a keen understanding of providers’ educational needs, learning science, and creative storytelling.
PharmExec
OCTOBER 19, 2022
The acquisition by ILSL Inc., a subsidiary of Indegene Private Limited, augments Indegene’s commercialization portfolio spanning drug discovery and development to marketing and sales, adding brand strategy, market development capabilities, and patient engagement platforms.
Drug Store News
OCTOBER 19, 2022
The warehouse club division of Walmart now performs floor scrubbing and inventory scanning with autonomous in-store robots across its entire chain.
Let's personalize your content